Madrigal Pharmaceuticals to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference

Rhea-AI Summary

Madrigal Pharmaceuticals (NASDAQ:MDGL) announced its upcoming participation in the Morgan Stanley 23rd Annual Global Health Care Conference. The presentation is scheduled for Monday, September 8, 2025, at 7:45 A.M. EDT.

Investors can access the live webcast through the provided link or via Madrigal's Investor Relations Events and Presentations page. A replay will be made available following the event.

News Market Reaction

-0.19%

1 alert

-0.19% News Effect

On the day this news was published, MDGL declined 0.19%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

CONSHOHOCKEN, Pa., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) today announced that the company will participate in the Morgan Stanley 23^rd Annual Global Health Care Conference on Monday, Sept. 8, 2025 at 7:45 A.M. EDT.

The presentation will be webcast live and may be accessed here or by visiting Madrigal’s Investor Relations Events and Presentations page. A replay of the webcast will be available after the event.

About Madrigal
Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a liver disease with high unmet medical need. Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c). For more information, visit www.madrigalpharma.com.

Investor Contact
Tina Ventura, IR@madrigalpharma.com

Media Contact
Christopher Frates, media@madrigalpharma.com

FAQ

When is Madrigal Pharmaceuticals (MDGL) presenting at the Morgan Stanley Healthcare Conference 2025?

Madrigal Pharmaceuticals will present at the Morgan Stanley Healthcare Conference on Monday, September 8, 2025 at 7:45 A.M. EDT.

How can investors access Madrigal Pharmaceuticals' (MDGL) Morgan Stanley conference presentation?

Investors can access the presentation through the live webcast link provided by the company or by visiting Madrigal's Investor Relations Events and Presentations page. A replay will be available after the event.

Will there be a replay available of Madrigal Pharmaceuticals' (MDGL) Morgan Stanley conference presentation?

Yes, a replay of the webcast will be made available on Madrigal's website after the event.

What is the purpose of Madrigal Pharmaceuticals' (MDGL) participation in the Morgan Stanley conference?

Madrigal Pharmaceuticals will participate in the Morgan Stanley 23rd Annual Global Health Care Conference to present company updates and information to investors and industry professionals.